On September 1st, a new television campaign for the APAP brand was launched. In the commercial, featuring a train conductor as the protagonist, it is emphasized that APAP is released within 3 minutes¹ and does not burden the heart². The advertisement showcases the new packaging of APAP brand products.

Our groundbreaking new product – APAP Caps has also premiered. It is the first liquid capsule paracetamol in Poland, which absorbs twice as fast³. The product is a global innovation and begins a completely new chapter in the history of the APAP brand.

We invite you to watch the spot.

¹ Initiation of APAP release in artificial gastric juice at pH 1.2, temp. 37°C, internal data, Wrocław 06.2019

² Does not burden the heart – results from the properties of paracetamol

³ Relates to paracetamol as an active substance, coated tablet vs capsule. Source CHPL APAP Caps: max plasma concentration: after 15 min to 1.5 hours vs from 30 min to 2 hours

APAP coated tablets, APAP Caps soft capsules

Paracetamol 500 mg

Indications for use: Apap: pain of various etiologies: headaches (including tension headaches), menstrual pain, toothaches, muscle pain, bone-joint pain, sore throat, neuralgia, and fever, e.g., in colds and flu. APAP Caps: symptomatic treatment of mild to moderate pain and/or fever.

Contraindications: hypersensitivity to paracetamol or any of the excipients. Severe liver or kidney failure. Congenital deficiency of glucose-6-phosphate dehydrogenase and methemoglobin reductase. APAP Caps allergy to peanuts or soy. Apap and Apap Caps: Do not use in children under 12 years old.

Entity responsible: US Pharmacia Sp. z o.o.

Before use, read the leaflet which contains indications, contraindications, data on adverse effects and dosage, and information regarding the use of the medicinal product, or consult a doctor or pharmacist, as any medication improperly used threatens your life or health.